NAD

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series

Retrieved on: 
Monday, August 7, 2023
Research, Science, Ageing, Nicotinamide adenine dinucleotide, NAD, Google Chrome, ChromaDex

ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Monday, August 14, 2023, at 12:00 p.m.

Key Points: 
  • ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Monday, August 14, 2023, at 12:00 p.m.
  • ET (9:00 a.m. PT) and Wednesday, August 16, 2023 at 2:00 p.m.
  • ChromaDex welcomes stakeholders, investors, and other individual followers to register and attend these live events.
  • Investors may submit questions during the presentations or may email questions to [email protected] or [email protected] ahead of the event.

Introducing Age No More: The Ultimate Caffeinated Energy Beverage for Enhanced Vitality and Youthfulness

Retrieved on: 
Thursday, July 27, 2023
Natural Resources, Health, Specialty, Food, Beverage, Fitness & Nutrition, Other Natural Resources, Cannabis, Retail, Heart, Quercetin, Elasticity, Lion, Radical, Nicotinamide adenine dinucleotide, Andrographis, Urolithin A, Bacopa monnieri, NAD, Multimedia, Caffeine, Anti-aging product, Cordyceps, Brain Age 2: More Training in Minutes a Day!, MD, Head, CBD, Resveratrol, Dietary supplement

Age No More is not just an energy drink; it's a step toward a more vibrant and youthful you.

Key Points: 
  • Age No More is not just an energy drink; it's a step toward a more vibrant and youthful you.
  • View the full release here: https://www.businesswire.com/news/home/20230727800106/en/
    Each 12 fl Oz serving of Age No More delivers an invigorating boost with 180mg of caffeine, providing the energy you need to tackle the day head-on.
  • Additionally, Age No More incorporates 20mg of CBD sourced from full spectrum hemp, offering a sense of calm and balance to your experience.
  • NAD+ (Nicotinamide Adenine Dinucleotide) is a vital coenzyme responsible for cellular energy production and plays a significant role in the anti-aging process.

Findings from Published Abstracts Showcase the Importance of Nicotinamide Adenine Dinucleotide (NAD+) in Glaucoma Patients and that Supplementation with Nicotinamide Riboside (NR) Demonstrate Promising Effects

Retrieved on: 
Tuesday, July 18, 2023
Seniors, Biotechnology, Pharmaceutical, Optical, General Health, Health, Consumer, Clinical Trials, Glaucoma, Abstract, ARVO, Li Ka Shing Faculty of Medicine, NR, Eye, Control, NAD, UCL Institute of Ophthalmology, Research, ChromaDex, Trial of the century, School of Clinical Medicine, University of Cambridge, Medicine, Moorfields Eye Hospital, Patient, Peripheral vision, Randomness, School, Investigative Ophthalmology & Visual Science, Optic nerve, Association for Research in Vision and Ophthalmology, Regulatory affairs, Medical device, Medical imaging, Ophthalmology

Together, the promising results from these abstracts suggest that glaucoma patients have lower cellular NAD+ levels and thus replenishing NAD+ levels with a precursor, such as nicotinamide riboside (NR), may be a potential therapeutic strategy.

Key Points: 
  • Together, the promising results from these abstracts suggest that glaucoma patients have lower cellular NAD+ levels and thus replenishing NAD+ levels with a precursor, such as nicotinamide riboside (NR), may be a potential therapeutic strategy.
  • Dr. Garway-Heath’s abstract titled “ Primary open angle glaucoma patients have lower systemic mitochondrial function, associated with lower systemic nicotinamide adenine dinucleotide (NAD) levels, compared to Controls ” observed significantly lower cellular NAD+ levels and impaired mitochondrial function in patients with primary open-angle glaucoma (POAG).
  • Further, higher NAD+ levels were strongly associated with higher mitochondrial function parameters, suggesting increased NAD+ levels are associated with improved energy production and cellular activity.
  • POAG is a condition where pressure builds inside the eye, causing damage to the optic nerve and gradual vision loss.

ChromaDex, a Global Authority on Nicotinamide Adenine Dinucleotide (NAD+), Celebrates the 10th Anniversary of its ChromaDex External Research Program (CERP™), the Industry Leading Research Program Advancing the Science of NAD+ and Healthy Aging

Retrieved on: 
Friday, June 16, 2023
Health, Hospitals, Other Health, General Health, Pharmaceutical, Vitamins, Supplements, Biotechnology, University of Helsinki, Science, Human, Cell Metabolism, University, PD, Heart failure, Metabolism, CERP, Science Advances, NR, Placebo, LVEF, Spinal cord, Research fellow, Clinical trial, Ageing, NAD, University of Oslo, Philip Morris External Research Program, ChromaDex, Research, Brain, Inflammation, Affiliation, Mitochondrion, DSM-IV codes, University of Washington School of Medicine, Trial of the century, Associate, Haukeland University Hospital, University of Bergen, City, Publication, Parkinson's disease, Patient, Division, Heart, University of Copenhagen Faculty of Health and Medical Sciences, University of Oulu, Diabetes, Safety, Copenhagen, Dietary supplement, Pharmaceutical industry, Medical device, Nicotinamide riboside, Cardiology

On June 13th, ChromaDex Corp. (NASDAQ:CDXC), a global authority on nicotinamide adenine dinucleotide (NAD+) research and healthy aging, celebrated the 10th anniversary of its award-winning ChromaDex External Research Program (CERP™).

Key Points: 
  • On June 13th, ChromaDex Corp. (NASDAQ:CDXC), a global authority on nicotinamide adenine dinucleotide (NAD+) research and healthy aging, celebrated the 10th anniversary of its award-winning ChromaDex External Research Program (CERP™).
  • On behalf of the ChromaDex family, we are thrilled to commemorate our ChromaDex External Research Program as it celebrates a decade of setting the industry standard for excellence in collaborative research,” said Rob Fried, the CEO of ChromaDex.
  • This approach fosters great trust in the research, as often there is skepticism around industry-funded research in the dietary supplement industry.
  • Today, this unique, industry-leading program has research agreements with over 200 institutions in 31 countries, representing over $95 million in estimated total research value.

Jinfiniti's NAD Scientist Warns: Beware Semaglutide Weight Loss Hype, Suggests Holistic Approach

Retrieved on: 
Tuesday, June 6, 2023
Exercise, Obesity, Diabetes, Life, Sleep, Weight loss, Research, Cell, Calorie, Internet, Philosophy, NAD, Metabolism, DSM-IV codes, Met, Longevity, Health, Pancreas disease in farmed salmon, Social media, Safety, Pharmaceutical industry, Dietary supplement, Semaglutide, Tao

The Internet and social media posts are ripe with the promise of quick weight loss by injecting Semaglutide.

Key Points: 
  • The Internet and social media posts are ripe with the promise of quick weight loss by injecting Semaglutide.
  • As an alternative to prescription Semaglutide, Jinfiniti Precision Medicine suggests using NAD supplements , to help achieve weight loss, safely.
  • NAD optimization improves metabolism and energy, and when combined with exercise and caloric restriction, it enhances any weight loss program.
  • In summary, the increasing popularity of Semaglutide for weight loss raises concerns about serious health risks from off-label use.

NOVOS Debuts Longevity Product Line, Leveraging Breakthrough Scientific Discoveries to Slow Down the Pace of Aging

Retrieved on: 
Wednesday, May 10, 2023
Health, Other Health, General Health, Research, Vitamins, Supplements, Science, Acceleration, Cognition, Fourth Estate Public Benefit Corporation, DNA, Drink, NAD, Doctor of Philosophy, PBC, Professional corporation, Ageing, NMN, Multimedia, MIT, Life expectancy, Calcium alpha-ketoglutarate, Harvard Medical School, Cellular senescence, Capsule, Salk Institute for Biological Studies, DNA repair, Metabolism, Mortality, Longevity, Glycine, Pharmaceutical industry, Dietary supplement, NOVOS

After four years of rigorous testing and formulating, NOVOS is now unveiling its line of science-backed, patent-pending supplements for consumers that aim to slow down the pace of aging by targeting its root causes.

Key Points: 
  • After four years of rigorous testing and formulating, NOVOS is now unveiling its line of science-backed, patent-pending supplements for consumers that aim to slow down the pace of aging by targeting its root causes.
  • The company has gone through multiple third-party research studies to assess the impact of its supplements on longevity and healthy aging.
  • In in-vitro human cell studies, NOVOS supplements were shown to reduce DNA damage from irradiation by up to 77% and inhibit cellular senescence.
  • As a Public Benefit Corporation (PBC), NOVOS is committed to educating consumers about healthy living, regularly publishing Ph.D. and M.D.-authored articles

Restore Hyper Wellness Opens 200th Studio

Retrieved on: 
Tuesday, April 25, 2023
Alternative Medicine, Health, Physical Therapy, Other Health, Fitness & Nutrition, General Health, Vitamins, Supplements, Entrepreneurship, NAD, Cryotherapy, IV, Film industry

Restore Hyper Wellness (Restore), a leading provider of proactive wellness services, opened its 200th studio, marking a major milestone for the growing brand.

Key Points: 
  • Restore Hyper Wellness (Restore), a leading provider of proactive wellness services, opened its 200th studio, marking a major milestone for the growing brand.
  • Restore Hyper Wellness Newport Beach, California takes the title of studio number 200 and is locally owned and operated by seasoned, multi-unit business partners Marc Thomas and Pete Selner.
  • The opening of our 200th studio marks another phenomenal milestone in our ability to bring Hyper Wellness to communities across the United States,” said Steve Welch, Co-Founder, Executive Chairman, and interim CEO.
  • Restore Hyper Wellness is one of the nation's largest and fastest growing wellness providers, having opened 67 locations in 2022 and now offering therapies in 40 states across the country.

Blaze Pizza Heats Up International Expansion with New Franchise Operator in Bahrain

Retrieved on: 
Monday, April 24, 2023
Bahraini, Growth, NAD, Social media, Guajardo, Focus Brands, Salad, Drink, Blaze Pizza, Fast food

LOS ANGELES, April 24, 2023 /PRNewswire/ -- Blaze Pizza, the nation's leading fast-casual franchise pizza concept, announced today it is fueling its international expansion in Bahrain with a multi-unit development agreement to open two new locations and acquire an existing Blaze Pizza in Bahrain's capital, Manama. The franchise agreement marks another milestone in the brand's continued growth around the globe, with 25 international locations across Canada, Saudi Arabia and United Arab Emirates.

Key Points: 
  • LOS ANGELES, April 24, 2023 /PRNewswire/ -- Blaze Pizza , the nation's leading fast-casual franchise pizza concept, announced today it is fueling its international expansion in Bahrain with a multi-unit development agreement to open two new locations and acquire an existing Blaze Pizza in Bahrain's capital, Manama.
  • Spearheading the latest international development is Nabeel Dabwan, President and principal owner of NAD Tradings, a leading Bahrain-based international restaurant group and current Cinnabon® operator.
  • "We believe that Blaze Pizza has the potential to be a truly global brand, and we are excited to work with international franchise partners, like Nabeel and his team, who share our vision for growth and success," said Beto Guajardo, CEO of Blaze Pizza.
  • We look forward to supporting this expansion and Nabeel's growth with Blaze Pizza in Bahrain."

FREEMAN SIGNIFICANTLY INCREASES GRADE, OUNCES AND CONFIDENCE IN UPDATED RESOURCE ESTIMATE FOR THE LEMHI GOLD DEPOSIT, IDAHO

Retrieved on: 
Monday, April 10, 2023
Database, Mineral, National Spatial Reference System, CIM, Lemhi, North American Datum, Marketing, Mineral resource estimation, Universal Transverse Mercator coordinate system, UTM, MRE, Metallurgy, NAD, Gold, Igneous intrusion, Reserve, NI, Mining, Mineral Resources Limited, Uranium mining, Petroleum

The Inferred Mineral Resource in this estimate has a lower level of confidence than that applied to an Indicated Mineral Resource and must not be converted to a Mineral Reserve.

Key Points: 
  • The Inferred Mineral Resource in this estimate has a lower level of confidence than that applied to an Indicated Mineral Resource and must not be converted to a Mineral Reserve.
  • It is reasonably expected that the majority of the Inferred Mineral Resource could potentially be upgraded to an Indicated Mineral Resource with continued exploration.
  • The estimate of Mineral Resources may be materially affected by environmental, permitting, legal, title, taxation, socio-political, marketing, or other relevant issues.
  • The effective date for the drill hole database used to produce this mineral resource estimate is February 1, 2023.

Biostarks Announces the Launch of the Groundbreaking Longevity Test Kits

Retrieved on: 
Friday, March 17, 2023
Hormone, Senescence, Vitamin, NAD, Mineral, Longevity, Oxidative stress, Dicarboxylic acid, Bottled water, Retail

SOUTH JORDAN, Utah, March 17, 2023 /PRNewswire/ -- Biostarks, a digital health company, is pleased to announce the launch of its innovative at-home longevity test kits.

Key Points: 
  • SOUTH JORDAN, Utah, March 17, 2023 /PRNewswire/ -- Biostarks, a digital health company, is pleased to announce the launch of its innovative at-home longevity test kits.
  • After a successful entry in the nutrition and sport markets with two respective at-home test kits leveraging its innovative mass-spectrometry platform, the company is expanding its offering in the fast-growing longevity market with two new products in the space.
  • The base longevity at home test-kit, to be commercialized as early as of April 2023, measures intracellular NAD+ and 3 essential minerals.
  • Longevity and health enthusiasts can already pre-order their premium longevity test-kit at a preferred price on https://biostarks.com/longevity/prelaunch ahead of the summer launch.